News & Events

• March 16, 2023
  

  Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature

  According to the latest guidelines by the Infectious Disease Society of America (IDSA), there is no defined standard of care for Acinetobacter baumannii infections, especially the ones with carbapenem resistant phenotypes. The IDSA guidelines do not comment on the utility of cefoperazone sulbactam since this an old drug that is no longer available in the......
• February 16, 2023
  

  Leveraging the SCCM Discovery Virus COVID-19 Registry to Evaluate Drug Repurposing Research Dataset

  Leveraging the SCCM Discovery Virus COVID-19 Registry to Evaluate Drug Repurposing Research Dataset

• September 21, 2022
  

  Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports

• January 31, 2022
  

  The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions

  The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.

• October 5, 2021
  

  Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19